A single-center, retrospective analysis assessing the effect of CFTR modulator therapies on cystic fibrosis patients in the United States
Latest Information Update: 14 Jan 2022
At a glance
- Drugs Elexacaftor/ivacaftor/tezacaftor (Primary) ; Ivacaftor/lumacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
Most Recent Events
- 14 Jan 2022 New trial record
- 15 Nov 2021 Results presented at The Liver Meeting 2021: 72nd Annual Meeting of the American Association for the Study of Liver Diseases